OWKIN

💥 Owkin K Navigator launches on the 6th of May. Our free-to-use agentic AI co-pilot for researchers across the world, to enhance the productivity of biological research and drive breakthrough discoveries. Kountdown to K begins now. Sign up here → https://lnkd.in/eY-vFAqs

Immune cells play critical role in GBM and create an immunosupressive environment. Our GBM MOSAIC research cohort - the only in the world of this depth and size can help exploring more to better spatially charactzerize those cells and localize them within the TEM, and understand which pathways inibit them and how to create therapeutic intervention. Great post from Jean-Frederic Petit-Nivard OWKIN CBO. AI spatial biology is just starting, OWKIN K is ready to help copilot alls related research and breakthrough.

In our latest Partners in Science episode, Philip Payne, Chief Health AI Officer from Washington University School of Medicine in St. Louis discusses how we can get AI to show real world medical impact. Owkin and Washington University School of Medicine in St. Louis are partnering to work on integrating multiscale real world data types through AI. This kind of advancement can be used for hypothesis generation and better diseases subtyping. Watch the full interview to see how this partnership is using AI to reshape our understanding of biomedical science.

Kountdown to K Navigator’s launch on May 6th - let us introduce the multiomic data visualization tool, K-multiomics, able to navigate and visualize complex multiomic patient data, featuring: 📑 Flexible plot generation 🧠 Natural language input 👥 TCGA and MOSAIC Window data access Create and iterate graphs from multimodal patient data to help you test and refine your hypotheses. Distill the science with fast biomedical literature search through natural language and incorporate knowledge from 17 other databases with our other tools, K-literature and K-Knowledge. K Navigator is free to use for academic researchers. Sign up here: https://lnkd.in/eY-vFAqs

🇺🇸 #AACR25 is right around the corner! Don’t miss our presentation ‘Harnessing Spatial Biology and Agentic AI to Optimize ADC Clinical Development Strategies’ on Tuesday, April 29th at 10:00 AM in Spotlight Theater D. We will discuss how our AI co-pilot, Owkin K, uses Agentic AI and multi-omics data to overcome challenges in ADC development through biomarker discovery, patient stratification, and a NECTIN4 case study.

🚀 Exciting discussions at World CB & CDx Summit Europe! Our Director of Commercial Strategy & Operations, Antoine de Sagey, joined AstraZeneca’s Thomas Di Maio to explore how AI-driven diagnostics can transform patient identification, accelerate gBRCA genetic testing, and drive digital pathology adoption. At Owkin, we’re committed to leveraging AI Dx to advance oncology and improve patient outcomes. 💡

💡 How is AI transforming healthcare? That’s what our COO Alban de La Sablière discusses at the mic of the excellent François Sorel, host of the Tech & Co TV/Radio show on BFM Business at the AWS Summit in Paris. It’s an opportunity to gain a better understanding of the possibilities offered by AI in medical research and to better explain the value of having a solid partner like Amazon Web Services (AWS) to speed up discoveries. Joining Alban for the conversation are Camille Bouget, CEO of Scienta Lab, and Robin Chaudret, CTO of Qubit Pharmaceuticals. 🇫🇷 Watch the full interview → https://lnkd.in/eJEWy728

Jean-Philippe Vert crush it at Amazon Web Services (AWS) Paris summit introducing OWKIN K Navigator Connecting patients data to a new thinking system based on multimodal foundation models and finetuned LLM into one software is owkin k mission - towards biology artificial super intelligence and accelerated research for biology! Because biology is just too complex for the human mind! #goK

One year on: how has Owkin’s work in foundation models progressed since our 2024 Kaggle UBC-OCEAN winning project. Owkin’s Kaggle solution harnessed Phikon, our cutting-edge histology foundation model (https://lnkd.in/ez6aYFWQ) – and now we have published Phikon 2 and worked with Bioptimus on H0-mini. This blog highlights the game-changing power of foundation models - how they could revolutionize digital pathology and oncology while tackling complex medical challenges.

Tomorrow at the 13th ISSAID Congress, our Chief Medical Officer, Vassili Soumelis, will take the stage to explore how algorithms and AI are reshaping our understanding of Steroidal Anti-Inflammatory Diseases (SAIDs). His talk will focus on the AI-driven approaches to unravel the complex pathogenesis of SAIDs, paving the way for more targeted therapies in the field of auto-inflammatory diseases. 🔗 Learn more about the event: https://lnkd.in/guVJwvmk